Erratum

Article

An article authored by Josef Reiter, MD, titled "My way to Epi-LASIK", which appeared in the July/August issue of Ophthalmology Times Europe, contained an error on page 20.

An article authored by Josef Reiter, MD, titled “My way to Epi-LASIK”, which appeared in the July/August issue of Ophthalmology Times Europe, contained an error on page 20. A portion of the sentence appearing beneath the sidebar “Current Epi-LASIK medication regimen” was missing from the printed article. This should read as follows: Uncorrected and best-corrected visual acuity was initially a little better without the flap, about the same in both groups at one month, and slightly better in the flap group by three months (Figure 6).

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.